EurekaMag.com logo
+ Translate

Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants


, : Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants. Journal of Pediatrics 123(6): 975-982

Objective: To investigate whether intravenous administration of lipid nutrition (Intralipid) within 12 hours of birth to ventilator-dependent premature infants would decrease the incidence or severity, or both, of chronic lung disease. Method: We randomly assigned 133 infants to Intralipid or control groups, using two weight strata: 42 Intralipid versus 37 control subjects in the 600 to 800 gm stratum, and 28 Intralipid versus 26 control subjects in the 801 to 1000 gm stratum. The Intralipid group received 20% Intralipid at lt 12 hours after birth, starting at a dose of 0.5 gm/kg and increasing to a maximum of 1.5 gm/kg, maintained through day 7. Control infants received no lipid until after day 7. Neither group received enteral feedings until after day 7. Results: No significant differences in mortality rates were present in the total population (23/70 = 32.9% vs 16/63 = 25.4%; p = 0.35, Intralipid vs control); however, the mortality rate increased significantly in 600 to 800 gm Infants receiving Intralipid versus the control Infants (20/41 = 47.5% vs 9/37 = 24.3%; p = 0.032). No significant differences were found in the number of infants In whom chronic lung disease developed (requiring oxygen for gtoreq 28 days), proportion requiring oxygen for gtoreq 60 days, number of survivors without chronic lung disease, or total oxygen and ventilation requirements. However, 600 to 800 gm infants receiving Intralipid had significantly more pulmonary hemorrhage, and greater numbers of infants receiving Intralipid in both weight categories required supplemental oxygen at day 7. The incidence of other complications of prematurity, time required to regain birth weight, and duration of hospital stay did not differ between groups. Conclusion: Intralipid administration initiated at lt 12 hours after birth failed to protect very low birth weight premature infants from chronic lung disease. Some of the results raise questions about possible deleterious effects of Intralipid when administered early in the first week of life.

Accession: 002355305

PMID: 8229533

DOI: 10.1016/s0022-3476(05)80397-x

Download PDF Full Text: Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Fox, G.F.; Wilson, D.C.; Ohlsson, A., 1998: Effect of early vs late introduction of intravenous lipid to preterm infants on death and chronic lung disease Results of meta-analyses. Pediatric Research 43(4 PART 2): 214A, April

Yeh, T.F.; Lin, I.J.; Lin, H.C.; Shieh, W.S.; Chen, J.Y., 1994: Early surfactant and dexamethasone therapy reduce the incidence of chronic lung disease in premature infants. Pediatric Research 37(4 PART 2): 357A

Chiu, H-Yu.; Su, B-Hong.; Lin, T-Wen.; Lin, H-Chih., 2004: Evaluation of the severity of chronic lung disease in premature infants by pulse oximeter. Three parameters obtained by pulse oximeter were tested to assess the severity of chronic lung disease (CLD) in premature infants. The FiO2 required to keep oxygen saturation of 90% on pulse oximeter at rest condition was defined as FiO2Sp90. The...

Alwaidh, M.H.; Bowden, L.; Shaw, B.; Ryan, S.W., 1996: Randomised trial of effect of delayed intravenous lipid administration on chronic lung disease in preterm neonates. A recent sevenfold increase in the annual incidence of chronic neonatal lung disease (CNLD) on an intensive care unit was attributed to the early administration of intravenous lipid (IVL) in ventilated preterm neonates. When logistic regression wa...

Armanian, A-Mohammad.; Badiee, Z.; Afghari, R.; Salehimehr, N.; Hassanzade, A.; Sheikhzadeh, S.; Shariftehrani, M.; Rezvan, G., 2014: Reducing the incidence of chronic lung disease in very premature infants with aminophylline. The objective of this study is to assess the safety and preventative effects of aminophylline on the incidence of chronic lung disease (CLD) in very premature infants. This was a long follow-up randomized clinical trial. The prophylactic effect of...

Bental R.Y.; Cooper P.A.; Sandler D.; Wainer S., 1990: The effects of vitamin a therapy on the incidence of chronic lung disease cld in premature infants. Pediatric Research 27(4 PART 2): 296A

Berger, T.M., 2000: Increased aldehyde lipid peroxidation products in premature infants with chronic lung disease. Archives of Disease in Childhood. Fetal and Neonatal Edition 81(3): F235-F235

Stahl, G.E.; Spear, M.L.; Hamosh, M., 1986: Intravenous administration of lipid emulsions to premature infants. This article describes the mechanisms responsible for hydrolysis and clearance of triglyceride from the circulation and focuses on the factors that affect lipid clearance in the newborn infant. The potential beneficial and adverse effects of IV li...

Ogihara, T.; Hirano, K.; Morinobu, T.; Kim, H.S.; Hiroi, M.; Ogihara, H.; Tamai, H., 1999: Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease. Aim-To indicate the extent of lipid peroxidation induced by oxidative stress, by measuring aldehyde end products in biological samples. Methods-A highly specific gas chromatography and mass spectrometry (GC/MS) method was used to measure plasma co...

Yeh, T.F., 1997: Prevention of chronic lung disease (CLD) in premature infants with early dexamethasone therapy. Pediatric Pulmonology. Supplement 16: 35-36